Literature DB >> 21843800

Bee venom induced cytogenetic damage and decreased cell viability in human white blood cells after treatment in vitro: a multi-biomarker approach.

Goran Gajski1, Vera Garaj-Vrhovac.   

Abstract

The aim of this study was to evaluate cytogenotoxic effects of bee venom to human lymphocytes and take a look into the mechanisms behind them. Bee venom was tested in concentrations ranging from 0.1μg/ml to 20μg/ml over different lengths of time. Cell viability, type of the cell death, and morphological alterations were evaluated using phase-contrast and fluorescent microscopy in addition to DNA diffusion assay, whereas cytogenotoxic effects were assessed with the micronucleus test. DNA damage and its relation to oxidative stress were evaluated combining the standard alkaline and the Fpg-modified comet assay. Our results showed lower cell viability, morphological cell alterations, cytogenotoxicity, and dominantly necrotic type of cell death in human lymphocytes after treatment with bee venom. All the effects were time- and dose-dependent. These results provide an insight into the effects of bee venom on the cell structure that could be relevant for therapeutic purposes.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21843800     DOI: 10.1016/j.etap.2011.05.004

Source DB:  PubMed          Journal:  Environ Toxicol Pharmacol        ISSN: 1382-6689            Impact factor:   4.860


  8 in total

Review 1.  Pharmacological effects and mechanisms of bee venom and its main components: Recent progress and perspective.

Authors:  Peiying Shi; Shihui Xie; Jiali Yang; Yi Zhang; Shuo Han; Songkun Su; Hong Yao
Journal:  Front Pharmacol       Date:  2022-09-27       Impact factor: 5.988

Review 2.  Biological Effects of Animal Venoms on the Human Immune System.

Authors:  Zharick Avalo; María Claudia Barrera; Manuela Agudelo-Delgado; Gabriel J Tobón; Carlos A Cañas
Journal:  Toxins (Basel)       Date:  2022-05-16       Impact factor: 5.075

3.  Antitumour action on human glioblastoma A1235 cells through cooperation of bee venom and cisplatin.

Authors:  Goran Gajski; Tamara Čimbora-Zovko; Sanjica Rak; Maja Osmak; Vera Garaj-Vrhovac
Journal:  Cytotechnology       Date:  2015-04-28       Impact factor: 2.058

4.  Neuronal Cell Death and Mouse (Mus musculus) Behaviour Induced by Bee Venom.

Authors:  Rian Oktiansyah; Berry Juliandi; Kanthi Arum Widayati; Vetnizah Juniantito
Journal:  Trop Life Sci Res       Date:  2018-07-06

5.  Rational design of an anti-cancer peptide inhibiting CD147 / Cyp A interaction.

Authors:  Zahra Maani; Safar Farajnia; Leila Rahbarnia; Elaheh Zadeh Hosseingholi; Nazli Khajehnasiri; Parisa Mansouri
Journal:  J Mol Struct       Date:  2022-09-16       Impact factor: 3.841

6.  Combined cytogenotoxic effects of bee venom and bleomycin on rat lymphocytes: an in vitro study.

Authors:  Yasmina M Abd-Elhakim; Samah R Khalil; Ashraf Awad; Laila Y Al-Ayadhi
Journal:  Biomed Res Int       Date:  2014-04-16       Impact factor: 3.411

7.  Design and activity study of a melittin-thanatin hybrid peptide.

Authors:  Xiaofeng Jiang; Kun Qian; Guangping Liu; Laiyu Sun; Guoqing Zhou; Jingfen Li; Xinqiang Fang; Haixia Ge; Zhengbing Lv
Journal:  AMB Express       Date:  2019-01-30       Impact factor: 3.298

8.  Chemical, Cytotoxic, and Anti-Inflammatory Assessment of Honey Bee Venom from Apis mellifera intermissa.

Authors:  Iouraouine El Mehdi; Soraia I Falcão; Mustapha Harandou; Saïd Boujraf; Ricardo C Calhelha; Isabel C F R Ferreira; Ofélia Anjos; Maria G Campos; Miguel Vilas-Boas
Journal:  Antibiotics (Basel)       Date:  2021-12-10
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.